Only 2/59 immune cell phenotypes showed significant differences in the comparison of PBMCs from healthy individuals and patients with neurological diseases: TCRαβ+CD4+CD25−CD107a+ T-cells expressed higher numbers of IL-7R molecules as compared to PBMCs obtained from control individuals. The gene discussed is CD4; the disease is nervous system disorder.